Diabetic retinopathy pathophysiology

40
PATHOPHYSIOLOGY OF DIABETIC RETINOPATHY

Transcript of Diabetic retinopathy pathophysiology

Page 1: Diabetic retinopathy pathophysiology

PATHOPHYSIOLOGY OF DIABETIC RETINOPATHY

Page 2: Diabetic retinopathy pathophysiology

Diabetic retinopathy

• Prevalence increases with– duration of diabetes – Poor control of diabetis– Pregnancy– Hypertension– nephropathy

Page 3: Diabetic retinopathy pathophysiology

PATHOGENESIS• Aldose reductase• Enzyme that converts sugar to alcohol (ie: glucose to

sorbitol)• Sarbitol cannot diffuse out of the cell easily – increase

intracellular concentration.• Osmotic forces draw water into the cell causing

electrolyte imbalance.• The resultant damage to lens epithelial cells, which have

a high concentration of aldose reductase, is responsible for the cataracts seen in children with galactosemia and in animals with experimental diabetes mellitus.

Page 4: Diabetic retinopathy pathophysiology

• Because aldose reductase is also found in high concentration in retinal pericytes and Schwann cells, some investigators suggest that diabetic retinopathy and neuropathy may be caused by aldose reductase-mediated damage.

Page 5: Diabetic retinopathy pathophysiology

VASOPROLIFERATIVE FACTORS

• Hypoxic retina produces a “vasoproliferative factor” that diffuses to nearby blood vessels inducing neovascularization.

• Vascular endothelial growth factor (VEGF) has been implicated in diabetic retinopathy.

• VEGF is found in the vitreous of patients with diabetic retinopathy and decreases after PRP.

• Experimental intravitreal injections of VEGF produce retinal ischemia and microangiopathy in primates.

• The use of anti-VEGF compounds in patients with diabetic retinopathy.

Page 6: Diabetic retinopathy pathophysiology

PLATELET AND BLOOD VISCOSITY

• Platelet abnormalities in diabetics may contribute to retinopathy.

• It has been shown that the platelets in diabetic patients are “stickier” than platelets of patients without diabetes.

• Once some platelets adhere to the basement membrane or to damaged cell walls, they secrete prostaglandins which cause other platelets to adhere to them (aggregation).

• Arachidonic acid -> prostaglandin (thromboxane A2)• Thromboxe A2 – potent vasoconstrictor and platelet

aggregating agent.

Page 7: Diabetic retinopathy pathophysiology

• It has been postulated that abnormal platelet adhesion and aggregation causes focal capillary occlusion and focal areas of ischemia in the retina, which in turn contribute to the development of diabetic retinopathy.

Page 8: Diabetic retinopathy pathophysiology

PATHOGENESIS OF DR

• Progressive dysfunction of the retinal vasculature secondary to chronic hyperglycemia

• Leads to vascular leakage, focal ischemia, retinal hypoxia and neovascularisation

• Thickening of BM and loss of pericytes, impairing oxygen and nutrient flow

• Final metabolic pathway unknown

Page 9: Diabetic retinopathy pathophysiology

STAGES OF DR

• Non-proliferative DR– Mild– Moderate– Severe

• Proliferative DR– Mild - moderate– High risk

• Macula edema– Early macula edema– CSME

Page 10: Diabetic retinopathy pathophysiology

MILD NPDR– Microaneurysm are the first ophthalmoscopically

detectable change in diabetic retinopathy.– Histologically, thickening of the capillary basement

membrane and pericytes dropout.–  Pericytes are mesothelial cells that surround and support

the retinal capillary endothelial cells. Normally there is one pericyte per endothelial cell.

–  the pericytes dies off and are decreased in number.– Their absence weakens the capillaries and permits thin-

walled dilatations, called microaneurysms, to develop.

Page 11: Diabetic retinopathy pathophysiology

MICROANEURYSM– Focal dilatation of the retinal capillaries due to loss of

pericytes

– 10-100 μm in size.

– Appear as a red dot on the superficial retinal layer.

– Fibrin and RBC can accumulate within aneurysms.

– Despite the multiple layers of basement membrane, microaneurysms are permeable to water and large molecules, allowing the transudation of fluid and lipid into the retina.

Page 12: Diabetic retinopathy pathophysiology
Page 13: Diabetic retinopathy pathophysiology

MODERATE NPDR

• Microaneurysms• Retinal hemorrhages DH /BH• Hard exudates • Cotton wool spot• Venous beading• IRMA

Page 14: Diabetic retinopathy pathophysiology

RETINAL HEMORRHAGE

• When the wall of a capillary or microaneurysm is thin, it may rupture, giving rise to an intraretinal hemorrhage.

• If the hemorrhage is deep ( ie; in the inner nuclear layer or the outer plexiform layer )

• Dot or blot hemorrhage

• Superficial hemorrhage (ie; nerve fiber layer)• Flame or splinter- shape

Page 15: Diabetic retinopathy pathophysiology

RETINAL HEMORRHAGE

Page 16: Diabetic retinopathy pathophysiology

RETINAL HEMORRHAGE

SPLINTER HEMORRHAGE

DOT /BLOT HEMORRHAGE

Page 17: Diabetic retinopathy pathophysiology

Hard exudates• Yellow deposit of lipid

and protein within the sensory retinal layer.

• Due to leaking from the microaneurysm.

• Outer plexiform and inner nuclear layer.

• Accumulation may cause a circinate pattern– it accumulates in a ring

around a group of leaking microaneurysms.

Page 18: Diabetic retinopathy pathophysiology

COTTON WOOL SPOT

• Nerve fiber layer infarcts.• Also known as soft exudates.• Result from occlusion of the pre-capillary arterioles that

supply the nerve fiber layers.• Local ischemia causes effective obstruction of

axoplasmic flow in the nerve fiber layer.

• Subsequent swelling of the nerve fibers gives a characteristic white fluffy appearance to the cotton wool spot.

• Flourescein angiography shows no capillary perfusion in the area corresponding to the cotton wool spot.

Page 19: Diabetic retinopathy pathophysiology

COTTON WOOL SPOT

Page 20: Diabetic retinopathy pathophysiology

VENOUS BEADING

• Saccular bulges of the wall of retinal veins .

• Indicates sluggish retinal circulation and are nearly always adjacent to extensive areas of capillary nonperfusion.

• May represent an area of endothelial proliferation that fail to develop into new vessels.

• Capillaries next to areas of nonperfusion that dilate and function as collaterals are referred to as IRMA.

Page 21: Diabetic retinopathy pathophysiology

IRMA

• Remodelled capillary bed without any proliferative changes

• Collateral vessels seen on FFA, no leakage• Usually found in borders of non-perfused retina

Page 22: Diabetic retinopathy pathophysiology

• IRMA are frequently difficult to differentiate from surface retinal neovascularization.

• Fluorescein, however, does not leak from IRMA but leaks profusely from neovascularization.

Page 23: Diabetic retinopathy pathophysiology

VENOUS BEADING IRMA

Page 24: Diabetic retinopathy pathophysiology

SEVERE NPDR

• All of the above plus 4:2:1 rule from ETDRS– DH / BH in all 4 quadrants.– Venous beading in 2 quadrants or more.– IRMA in 1 quadrant or more.

Page 25: Diabetic retinopathy pathophysiology

PDR

• Mild / moderate PDR– mild NVD / NVE

• High risk PDR– NVD about 1/3 Disc

area– Any NVD plus VH– NVE > ½ DD with VH

Page 26: Diabetic retinopathy pathophysiology

What happens in PDR

• New blood vessels arise from the endothelial cells of post-capillary venules

• Evolve in 3 stages– Fine NV formation with minimal fibrous tissue

extend beyond ILM– NV increase in size and fibrous component– NV regress, leaving fibrovascular proliferation

along post hyaloid

Page 27: Diabetic retinopathy pathophysiology

• In new vessel formation, the endothelial cells have to– become activated – be released from its surroundings – migrate – proliferate

Page 28: Diabetic retinopathy pathophysiology

Endothelial cell activation• Ischaemic retina release local growth factors

that activate endothelial cells in healthy capillaries at the edge of the ischaemic area

• VEGF is released by the retinal pigment epithelial cells in response to hypoxia

• Also produced by RPE in response to hyperglycaemia through activation of the protein kinase C pathway

• Other sources include the platelets and white blood cells that occlude the capillaries

Page 29: Diabetic retinopathy pathophysiology

• Breakdown of BM causes migration of endothelial cells

• Laminin, a major component of the basement membrane, causes angiogenesis when degraded

• Breakdown of collagen, found in BM, also has to occur for angiogenesis

Page 30: Diabetic retinopathy pathophysiology

Migration and proliferation• Endothelial cells then migrate from the post-capillary

venules into the surrounding tissue • As they migrate, more cells and tubes are formed• Pairs of tubes join together thus forming loops• The top of the loop then forms further tubes that go

through the same process producing further loops• Controlled by urokinase-type plasminogen activator

(UPA) and TGF beta• In response to VEGF

– UPA stimulates cells to migrate– TGF beta matures the proliferated cells into capillary tubes

Page 31: Diabetic retinopathy pathophysiology

• New vessels grow from the walls of post-capillary venules

• Always form loops, and loop back to the originating vessel

• The diameter is often bigger than the vessel they originated from

• Grow between the inner surface of the retina and the vitreous

Page 32: Diabetic retinopathy pathophysiology

• May grow into the posterior hyaloid face

• Results in an inflammatory response and scar formation

• Contraction results in – NV being pulled forward

and appearing to stand up – NV tearing , leading to

hemorrhage– combination of both

Page 33: Diabetic retinopathy pathophysiology

• New vessels always grow on a platform of glial cells• If the new vessel component predominates then vitreous

haemorrhage occurs• Sometimes the glial cells predominate.• Glial cells associated with new vessels growing along the

major vascular arcades are particularly at risk• The reaction between the glial cells and the vitreous

results in scar formation• These scars contract, causing retinal folds and

eventually TRD

Page 34: Diabetic retinopathy pathophysiology

MACULAR EDEMA

• Intercellular fluid from leaking microaneurysms or diffuse capillary incompetence

• The fluid initially located between the outer plexiform layer and inner nuclear layer.

• Later, it may also involve the inner plexiform and nerve fiber layers,until the entire full thickness of the retina becomes edematous.

Page 35: Diabetic retinopathy pathophysiology

CLINICALLY SIGNIFICANT MACULAR EDEMA

• Retinal thickening within 500micrometer of the centre of the macula.

• Exudate within 500 micrometer of the centre of macula.

• Retinal thickening one disc area (1500 micrometer) or larger,any part of which is within one disc diameter of the centre of the macula.

Page 36: Diabetic retinopathy pathophysiology

CSME

Page 37: Diabetic retinopathy pathophysiology

Diabetic maculopathy

Page 38: Diabetic retinopathy pathophysiology

Advanced Diabetic Eye Disease• Serious vision- threatening complication of DR that occur

in patients in whom treatment has been inadequate or unsuccessful.

• Clinical feature :• Hemorrhages – may be preretinal (retrohyaloid),intragel

or both.• Tractional retinal detachment – cause by progressive

contraction of fibrovascular membranes over areas of vitroretinal attachment.

• Rubeosis iridis – iris neovascularization (NVI)• May lead to glaucoma• NVI particularly common in eyes with severe retinal

ischemia.

Page 39: Diabetic retinopathy pathophysiology
Page 40: Diabetic retinopathy pathophysiology

THANK YOU